Selected Safety Information – Melanoma References: AE-OOC-00011 | Exp : 30 July 2025BH-OOC-00002 | Exp : 30 July 2025AE-KEY-00399 | Exp : 30 July 2025
Selected Safety Information KSA KEYTRUDA® (PEMBROLIZUMAB) SELECTED SAFETY INFORMATION (SSI) Selected Indications:Non-small cell lung carcinoma (NSCLC)KEYTRUDA as monotherapy is indicated for the first-line treatment […]